Growth Metrics

Palvella Therapeutics (PVLA) Equity Ratio (2013 - 2026)

Palvella Therapeutics (PVLA) reported Equity Ratio of 0.88 for Q1 2026, up 25.89% year-over-year from 0.7 in Q1 2025, and up 87.46% on a QoQ basis from 0.47 in Q4 2025.

Palvella Therapeutics (PVLA) has 14 years of Equity Ratio data on file, last reported at 0.88 in Q1 2026.

  • Quarterly Equity Ratio rose 25.89% year-over-year to 0.88 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.88 (up 25.89% YoY) and the FY2025 annual result came in at 0.47, down 33.78% from the prior year.
  • Equity Ratio advanced to 0.88 in Q1 2026 per PVLA's latest filing, from 0.47 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.88 in Q1 2026 and bottomed at 9.87 in Q4 2023.
  • The 5-year median for Equity Ratio is 0.43 (2022), against an average of 0.94.
  • The widest annual swing landed in 2024, when Equity Ratio plunged 1486.82%; it then surged 126.85% in 2025.
  • Tracing PVLA's Equity Ratio over 5 years: stood at 0.98 in 2022, then tumbled by 904.82% to 9.87 in 2023, then surged by 107.19% to 0.71 in 2024, then sank by 33.78% to 0.47 in 2025, then soared by 87.46% to 0.88 in 2026.
  • Per Business Quant, the three latest PVLA Equity Ratio figures stand at 0.88 (Q1 2026), 0.47 (Q4 2025), and 0.58 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 0.04
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 0.42
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.73
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.77
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.21
10 Palvella Therapeutics 1.47 Bn 1.21 Bn - 0.88

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.88
Dec 31, 2025 0.47
Sep 30, 2025 0.58
Jun 30, 2025 0.65
Mar 31, 2025 0.70
Dec 31, 2024 0.71
Sep 30, 2024 -4.26
Jun 30, 2024 -3.23
Mar 31, 2024 -2.61
Dec 31, 2023 -9.87
Sep 30, 2023 0.51
Jun 30, 2023 0.46
Mar 31, 2023 0.19
Dec 31, 2022 -0.98
Jun 30, 2022 0.39
Mar 31, 2022 0.39
Dec 31, 2021 0.33
Sep 30, 2021 0.33
Jun 30, 2021 0.30
Mar 31, 2021 0.33
Dec 31, 2020 0.30
Sep 30, 2020 0.38
Jun 30, 2020 0.40
Mar 31, 2020 0.40
Dec 31, 2019 0.36
Sep 30, 2019 0.18
Jun 30, 2019 0.15
Mar 31, 2019 0.23
Dec 31, 2018 0.28
Sep 30, 2018 0.33
Jun 30, 2018 0.34
Mar 31, 2018 0.29
Dec 31, 2017 0.11
Sep 30, 2017 0.05
Jun 30, 2017 0.09
Mar 31, 2017 0.29
Dec 31, 2016 0.72
Sep 30, 2016 0.72
Jun 30, 2016 0.80
Mar 31, 2016 0.73
Dec 31, 2015 0.92
Sep 30, 2015 0.93
Jun 30, 2015 0.77
Mar 31, 2015 0.85
Dec 31, 2014 0.82
Sep 30, 2014 -4.11
Jun 30, 2014 0.90
Mar 31, 2014 -24.38
Dec 31, 2013 0.08
Jun 30, 2013 0.91